Natalia Andreeva
About Natalia Andreeva
Natalia Andreeva is the Health Economics and Pricing Lead at Bristol-Myers Squibb, with a background in pricing strategies and molecular biotechnology.
Current Position at Bristol-Myers Squibb
Natalia Andreeva currently serves as the Health Economics and Pricing Lead at Bristol-Myers Squibb. She has been leading health economics and pricing initiatives for the company since June 2017. Her role involves developing and implementing strategies to optimize pricing and economic models, ensuring the company's offerings remain competitive in the market.
Previous Experience at Bayer
Natalia Andreeva worked at Bayer as the Pricing Lead for the Russia and CEE region from 2016 to 2017. During her tenure, she focused on formulating and executing pricing strategies tailored for the regional markets. Her responsibilities included analyzing market conditions, regulating price points, and ensuring compliance with regional pricing regulations.
Academic Background and PhD
Natalia Andreeva holds a PhD in an unspecified field from Universität Wien, which she completed between 2004 and 2008. Additionally, she earned a degree from Lomonosov Moscow State University (MSU), where she studied from 1999 to 2004. Her academic background has provided her with a strong foundation in both theoretical and practical aspects of her work.
Tenure at Institute of Molecular Biotechnology
Natalia Andreeva gained valuable experience at the Institute of Molecular Biotechnology in Vienna, Austria, where she worked for five years from 2004 to 2009. Her role involved research in molecular biotechnology, contributing significantly to the field through her studies and findings.
Brief Period at Rutgers University
Between 2003 and 2004, Natalia Andreeva worked at Rutgers University. During her eight-month tenure, she contributed to various research and academic projects, further honing her skills and expanding her knowledge base.